Development of a first-in-class inhibitor of FIH for cancer immunotherapy

The project aims to valorise novel small molecule inhibitors of Factor Inhibiting HIF for lung cancer treatment by clarifying IP, engaging investors, and advancing drug candidate development.

Subsidie
€ 150.000
2022

Projectdetails

Introduction

We plan to carry out a valorisation project for a series of novel small molecule inhibitors of Factor Inhibiting HIF (FIH) that we have developed for the treatment of lung cancer, as a next-generation therapeutic approach in the field of immuno-oncology.

Valorisation Plan

The valorisation plan will include:

  • Clarification of IP rights and strategy
  • Establishing contacts with potential investors and pharma partners
  • Verification of the potential for start-up creation

Lead Optimisation Campaign

Moreover, valorisation activities will include the progression of hits against FIH into a lead optimisation campaign with the aim of designating a candidate drug.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 150.000
Totale projectbegroting€ 150.000

Tijdlijn

Startdatum1-6-2022
Einddatum30-11-2023
Subsidiejaar2022

Partners & Locaties

Projectpartners

  • ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIASpenvoerder

Land(en)

Spain

Vergelijkbare projecten binnen European Research Council

ERC STG

MANUNKIND: Determinants and Dynamics of Collaborative Exploitation

This project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery.

€ 1.497.749
ERC STG

Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressure

The UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance.

€ 1.498.280
ERC STG

The Ethics of Loneliness and Sociability

This project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field.

€ 1.025.860
ERC STG

Uncovering the mechanisms of action of an antiviral bacterium

This project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function.

€ 1.500.000

Vergelijkbare projecten uit andere regelingen

EIC Transition

Targeting OGG1 in Idiopathic Pulmonary Fibrosis

The TOPFIBRO project aims to advance OXC-201, a novel IPF treatment, through efficacy validation, safety assessments, and regulatory preparations for first-in-human studies, targeting a market launch.

€ 2.499.998
EIC Transition

Pre-clinical validation and demonstration of PeptiCHIP: an immunopurification microfluidic device and software for (neo)antigen identification and prioritization

Valo Therapeutics is developing PeptiCHIP, a microfluidic device and algorithm to efficiently identify neoantigens for personalized cancer immunotherapy, enhancing patient response rates.

€ 2.226.280
EIC Accelerator

IOO: a novel assay to predict patient response to immune checkpoint inhibitors, optimising patient stratification to these therapies and tripling solid tumour patient outcomes in immuno-oncology.

The project aims to enhance cancer immunotherapy efficacy by developing a validated biomarker assay to predict patient responses, potentially doubling survival rates for lethal tumors.

€ 2.496.112
EIC Transition

Development and validation of a pan-cancer neutrophil biomarker test for predicting clinical benefit from immunotherapy based on flow cytometry analysis of blood samples

The NeutroFlow project aims to develop a non-invasive blood test using a flow cytometry assay to predict cancer immunotherapy benefits, enhancing patient outcomes and reducing costs.

€ 2.499.999